Cargando…
Changes in DNA methylation are associated with the development of drug resistance in cervical cancer cells
BACKGROUND AND PROPOSE: Changes in DNA methylation are associated with changes in somatic cell fate without the alteration of coding sequences. In addition to its use as a traceable biomarker, reversible DNA methylation could also serve as a therapeutic target. In particular, if the development of d...
Autores principales: | Chen, Chih-Cheng, Lee, Kuan-Der, Pai, Mei-Yu, Chu, Pei-Yi, Hsu, Chia-Chen, Chiu, Chia-Chen, Chen, Li-Tzong, Chang, Jang-Yang, Hsiao, Shu-Huei, Leu, Yu-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604021/ https://www.ncbi.nlm.nih.gov/pubmed/26464562 http://dx.doi.org/10.1186/s12935-015-0248-3 |
Ejemplares similares
-
HIC1 and RassF1A Methylation Attenuates Tubulin Expression and Cell Stiffness in Cancer
por: Chen, Chih-Cheng, et al.
Publicado: (2018) -
Identification of novel DNA methylation inhibitors via a two-component reporter gene system
por: Lin, Yi-Shiuan, et al.
Publicado: (2011) -
DNA methylation biomarkers for hepatocellular carcinoma
por: Fan, Guorun, et al.
Publicado: (2018) -
Gamma synuclein is a novel nicotine responsive protein in oral cancer malignancy
por: Hsu, Chia-Chen, et al.
Publicado: (2020) -
Speckle-type POZ protein functions as a tumor suppressor in non-small cell lung cancer due to DNA methylation
por: Yao, Sumei, et al.
Publicado: (2018)